Streetbeat News

Regulatory

AMZN

Amazon.com Inc. has successfully launched its inaugural satellites for Project Kuiper, marking a significant step towards establishing a global space internet system. The project aims to deploy over 3,000 satellites to deliver broadband service globally, particularly to underserved and remote areas. The launch was delayed by a year, and Amazon is under a mandate to launch half of its Kuiper constellation by 2026 to meet FCC licensing requirements. Amazon's Project Kuiper is a significant entrant in the competitive space internet domain, alongside contenders like SpaceX's Starlink.

Portfolio Pulse from Nabaparna Bhattacharya

October 07, 2023 | 7:55 pm

AZN

IONS

Ionis Pharmaceuticals announced new results from a 66-week analysis of exploratory cardiac endpoints in the Phase 3 NEURO-TTRansform study of eplontersen, a treatment for hereditary transthyretin-mediated amyloid polyneuropathy. The results showed stabilization or improvement in cardiac function and structure. Ionis and AstraZeneca are seeking regulatory approval for eplontersen in the U.S. and globally. AstraZeneca has exclusive rights to commercialize eplontersen outside the US. The FDA granted a PDUFA action date of Dec. 22, 2023.

Portfolio Pulse from Charles Gross

October 07, 2023 | 7:53 pm

GOOGL

MTCH

Alphabet Inc.'s CEO Sundar Pichai and Epic Games Inc. CEO Tim Sweeney are set to testify in a landmark antitrust trial regarding Google Play's potentially monopolistic policies. The trial, initiated by Epic Games, could reshape the app marketplace and put billions of dollars in revenue at risk. Google also faces antitrust challenges from consumers, nearly three dozen states, and Match Group Inc.

Portfolio Pulse from Nabaparna Bhattacharya

October 07, 2023 | 7:31 pm

PRPO

Precipio Inc has regained compliance with the Nasdaq Bid Price Rule, according to an SEC filing.

Portfolio Pulse from Benzinga Newsdesk

October 06, 2023 | 8:38 pm

ONCT

Oncternal Therapeutics has been granted an additional 180 days by Nasdaq to regain compliance with the minimum bid requirement, according to an SEC filing.

Portfolio Pulse from Benzinga Newsdesk

October 06, 2023 | 8:37 pm

ACST

Acasti Pharma Inc has filed for a shelf of up to 6.6 million common shares by selling stockholders, according to an SEC filing.

Portfolio Pulse from Benzinga Newsdesk

October 06, 2023 | 8:36 pm

WISA

WiSA Technologies has received a notification from Nasdaq stating that the company is not in compliance with the minimum bid price requirement for continued listing, according to an SEC filing.

Portfolio Pulse from Benzinga Newsdesk

October 06, 2023 | 8:36 pm

OXUS

Oxus Acquisition Corp has entered into a second amended and restated promissory note with Oxus Capital PTE. LTD, according to an SEC filing.

Portfolio Pulse from Benzinga Newsdesk

October 06, 2023 | 8:35 pm

NVS

The FDA has approved Novartis' Cosentyx as the first intravenous formulation interleukin-17A antagonist for rheumatic diseases. The new IV administration option will be available in Q4 of 2023.

Portfolio Pulse from Benzinga Newsdesk

October 06, 2023 | 8:24 pm

FRZA

Forza X1 Inc has received a notice of delisting or failure to satisfy a continued listing rule or standard from Nasdaq, according to an SEC filing.

Portfolio Pulse from Benzinga Newsdesk

October 06, 2023 | 8:20 pm